NOS3 and endothelial dysfunction: As abnormal eNOS occurs commonly among patients with hypertension (Cengiz et al., 2015; ALrefai et al., 2016), these findings highlight that the patients with endothelial dysfunction might benefit from the endothelium-protective potential of Rhy.